Ryman Healthcare Ltd
F:RH70
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ryman Healthcare Ltd
F:RH70
|
NZ |
|
Lenox Pasifik Investama Tbk PT
IDX:LPPS
|
ID |
|
Halliburton Co
NYSE:HAL
|
US |
|
A
|
Atlas Technologies Corp
TSE:9563
|
JP |
|
K
|
Kung Sing Engineering Corp
TWSE:5521
|
TW |
|
B
|
Ball Corp
F:BL8
|
US |
|
Ray Sigorta AS
IST:RAYSG.E
|
TR |
Wall St Price Targets
RH70 Price Targets Summary
Ryman Healthcare Ltd
According to Wall Street analysts, the average 1-year price target for RH70 is 6.81 EUR with a low forecast of 5.95 EUR and a high forecast of 8.45 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RH70's stock price target?
Price Target
6.81
EUR
According to Wall Street analysts, the average 1-year price target for RH70 is 6.81 EUR with a low forecast of 5.95 EUR and a high forecast of 8.45 EUR.
What is the Revenue forecast for Ryman Healthcare Ltd?
Projected CAGR
8%
Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for Ryman Healthcare Ltd?
Projected CAGR
78%
Over the last 14 years, the compound annual growth rate for Operating Income has been 1%. The projected CAGR for the next 3 years is 78%.
